Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 3,110 |
|
|||||
| News | - | ||||||
| Day High | 17.83 | Low High |
|||||
| Day Low | 17.46 | ||||||
| Etf Name | Etf Symbol | Market | Stock Type |
|---|---|---|---|
| Amplify Treatments Testing and Advancements ETF | GERM | AMEX | Exchange Traded Fund |
| Price Change | Price Change % | Etf Price | Last Trade
|
|
|---|---|---|---|---|
| 0.4434 | 2.57% | 17.726 | 15:15:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 17.49 | 17.46 | 17.83 | 17.726 | 17.2826 |
| Trades | Etfs Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 35 | 3,110 | 17.66 | 54,911 | - | 15.6701 - 21.70 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 19:00:00 | 100 | 17.726 | USD |
Amplify Treatments Testing and Advancements ETF Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 11.52M | - | - | - | 21.84 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Amplify Treatments Testi...
| Date | Time | Source | Heading |
|---|---|---|---|
| 3/26/2024 | 06:00 | GlobeNewswire Inc. | Amplify ETFs Declares March Income Distributions for its.. |
| 1/29/2024 | 05:45 | GlobeNewswire Inc. | Amplify ETFs Completes Acquisition to Reach $9.1 Billion AUM.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
GERM Historical
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 16.78 | 17.83 | 16.35 | 17.05 | 1,520 | 0.946 | 5.64% |
| 1 Month | 17.83 | 18.1799 | 16.32 | 17.25 | 1,675 | -0.104 | -0.58% |
| 3 Months | 18.69 | 19.00 | 16.32 | 17.98 | 1,924 | -0.964 | -5.16% |
| 6 Months | 15.94 | 20.195 | 15.94 | 18.23 | 2,309 | 1.79 | 11.20% |
| 1 Year | 20.71 | 21.70 | 15.6701 | 19.02 | 2,427 | -2.98 | -14.41% |
| 3 Years | 38.17 | 46.06 | 15.6701 | 33.05 | 6,032 | -20.44 | -53.56% |
| 5 Years | 25.30 | 46.06 | 15.6701 | 31.91 | 18,795 | -7.57 | -29.94% |
| The ETFMG Treatments, Testing and Advancements ETF (the Fund) seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the Prime Treatments, Testing and Advancements Index The Fund uses a passive or indexing approach to try to achieve its investment objective. Unlike many investment companies, the Fund does not try to beat the Index and does not seek temporary defensive positions when markets decline or appear overvalued other than those indicated in the Index. The Fund will use a replication strategy. A replication strategy is an indexing strategy that involves investing in the securities of the Index in approximately the same proportions as in the Index. |
